- Report
- August 2025
- 194 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- January 2026
- 187 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- December 2025
- 200 Pages
Global
From €2716EUR$2,990USD£2,345GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,521GBP
- Report
- January 2026
- 280 Pages
Global
From €2725EUR$3,000USD£2,353GBP
- Report
- May 2024
- 131 Pages
Global
From €3633EUR$3,999USD£3,136GBP
- Report
- May 2024
- 132 Pages
Global
From €3633EUR$3,999USD£3,136GBP
- Report
- October 2023
- 145 Pages
Global
From €2862EUR$3,150USD£2,470GBP
- Report
- August 2024
- 80 Pages
Japan
From €3179EUR$3,500USD£2,745GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2725EUR$3,000USD£2,353GBP
- Report
- June 2025
- 150 Pages
Global
From €2452EUR$2,699USD£2,117GBP
- Report
- May 2024
- 132 Pages
Global
From €3633EUR$3,999USD£3,136GBP
- Report
- February 2024
- 360 Pages
Global
From €7222EUR$7,950USD£6,235GBP
- Report
- December 2023
- 140 Pages
Global
From €4042EUR$4,450USD£3,490GBP
- Report
- April 2025
- 137 Pages
Asia Pacific
From €3134EUR$3,450USD£2,706GBP
- Report
- April 2025
- 136 Pages
Africa, Middle East
From €3134EUR$3,450USD£2,706GBP
- Report
- July 2024
- 150 Pages
Global
From €4042EUR$4,450USD£3,490GBP
- Report
- November 2020
- 199 Pages
Global
€4088EUR$4,500USD£3,529GBP
- Report
- June 2026
- 50 Pages
Global
From €2407EUR$2,650USD£2,078GBP

Bimatoprost is a medication used to treat glaucoma and other optical disorders. It is a prostaglandin analog, meaning it works by increasing the outflow of fluid from the eye, reducing intraocular pressure. Bimatoprost is available as a topical ophthalmic solution, and is the only prostaglandin analog approved for the treatment of glaucoma and ocular hypertension. It is also used to treat hypotrichosis, a condition characterized by inadequate or thinning eyelashes.
Bimatoprost is a widely used medication in the optical disorders drugs market. It is the most commonly prescribed prostaglandin analog for glaucoma and ocular hypertension, and is also used off-label for other conditions. Bimatoprost is generally well-tolerated, with few side effects.
Some companies in the Bimatoprost market include Allergan, Sun Pharmaceuticals, and Pfizer. Show Less Read more